Evaluation of safety and pharmacokinetic parameters of the PTI5803 product
Safety, pharmacokinetics and pharmacodynamics study of Leucettinib-21 in healthy subjects, Down Syndrom and Alzheimer patients
100 Clinical Results associated with Eurofins Optimed SAS
0 Patents (Medical) associated with Eurofins Optimed SAS
100 Deals associated with Eurofins Optimed SAS
100 Translational Medicine associated with Eurofins Optimed SAS